Symbol="CARA"
AssetType="Common Stock"
Name="Cara Therapeutic"
Description="Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on itching and pain by selectively targeting kappa opioid receptors in the United States. The company is headquartered in Stamford, Connecticut."
CIK="1346830"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4 STAMFORD PLAZA, 107 ELM STREET 9TH FLOOR, STAMFORD, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="169507000"
EBITDA="-87031000"
PERatio="None"
PEGRatio="0"
BookValue="2.531"
DividendPerShare="0"
DividendYield="0"
EPS="-1.48"
RevenuePerShareTTM="0.805"
ProfitMargin="-1.952"
OperatingMarginTTM="-2.018"
ReturnOnAssetsTTM="-0.289"
ReturnOnEquityTTM="-0.495"
RevenueTTM="43242000"
GrossProfitTTM="-56141000"
DilutedEPSTTM="-1.48"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.287"
AnalystTargetPrice="17.86"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="15.22"
PriceToBookRatio="3.399"
EVToRevenue="12.05"
EVToEBITDA="-5.31"
Beta="0.832"
num_52WeekHigh="12.98"
num_52WeekLow="2.57"
num_50DayMovingAverage="3.151"
num_200DayMovingAverage="7.32"
SharesOutstanding="53983000"
DividendDate="None"
ExDividendDate="None"
symbol="CARA"
open="3.07"
high="3.24"
low="3.05"
price="3.19"
volume="523015.00"
latest_trading_day="2023-08-03"
previous_close="3.09"
change="0.10"
change_percent="3.2362%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="1122859"
Change_recent_avg="-0.03"
Delta_recent_avg="0.24"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.86"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_negative_thumbnail_id_2="1105"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0138.jpeg"
image_neutral_thumbnail_id_1="594"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="650"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_positive_thumbnail_id_2="1002"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0164.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
